Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Praxis Precision Medicines (PRAX) Payables (2022 - 2025)

Praxis Precision Medicines (PRAX) has 4 years of Payables data on record, last reported at $24.6 million in Q4 2025.

  • For Q4 2025, Payables rose 96.58% year-over-year to $24.6 million; the TTM value through Dec 2025 reached $24.6 million, up 96.58%, while the annual FY2025 figure was $24.6 million, 96.58% up from the prior year.
  • Payables reached $24.6 million in Q4 2025 per PRAX's latest filing, down from $30.8 million in the prior quarter.
  • Across five years, Payables topped out at $30.8 million in Q3 2025 and bottomed at $5.8 million in Q4 2023.
  • Average Payables over 4 years is $15.4 million, with a median of $13.6 million recorded in 2022.
  • Peak YoY movement for Payables: crashed 60.37% in 2023, then surged 251.82% in 2025.
  • A 4-year view of Payables shows it stood at $14.7 million in 2022, then plummeted by 60.37% to $5.8 million in 2023, then soared by 115.44% to $12.5 million in 2024, then surged by 96.58% to $24.6 million in 2025.
  • Per Business Quant database, its latest 3 readings for Payables were $24.6 million in Q4 2025, $30.8 million in Q3 2025, and $28.8 million in Q2 2025.